Disarming fungal pathogens: Bacillus safensis inhibits virulence factor production and biofilm formation by Cryptococcus neoformans and Candida albicans

mBio

Volumn 8, Issue 5, 2017, Pages

  Mayer, François L ^a   Kronstad, James W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Capsule formation; Cell wall; Chitin; Chitinase; Interspecies interaction; Melanization

Indexed keywords

BACTERIAL POLYSACCHARIDE; CHITIN; CHITINASE; MELANIN; VIRULENCE FACTOR;

ANTIFUNGAL ACTIVITY; ARTICLE; BACILLUS; BACILLUS SAFENSIS; BIOFILM; CANDIDA ALBICANS; CELL CONTACT; CELL GROWTH; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; ENZYME ACTIVITY; FUNGAL CELL WALL; FUNGAL MELANIZATION; FUNGUS GROWTH; GENETIC ANALYSIS; GROWTH INHIBITION; MELANOGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGANISMAL INTERACTION; PHENOTYPE; PLANKTON; PRIORITY JOURNAL; ANTIBIOSIS; BIOSYNTHESIS; CELL WALL; CHEMISTRY; ENZYMOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; PATHOGENICITY; PHYSIOLOGY;

ANTIBIOSIS; BACILLUS; BIOFILMS; CELL WALL; CHITINASES; CRYPTOCOCCUS NEOFORMANS; HUMANS; MELANINS; MICROBIAL INTERACTIONS; VIRULENCE FACTORS;

EID: 85033682201     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01537-17     Document Type: Article

References (85)

1. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. 2012. Hidden killers: human fungal infections. Sci Transl Med 4:165rv13. https://doi.org/10.1126/scitranslmed.3004404.
2. Brown GD, Denning DW, Levitz SM. 2012. Tackling human fungal infections. Science 336:647. https://doi.org/10.1126/science.1222236.
3. Hogan LH, Klein BS, Levitz SM. 1996. Virulence factors of medically important fungi. Clin Microbiol Rev 9:469–488.
4. Mayer FL, Wilson D, Hube B. 2013. Candida albicans pathogenicity mechanisms. Virulence 4:119–128. https://doi.org/10.4161/viru.22913.
5. Kronstad JW, Attarian R, Cadieux B, Choi J, D’Souza CA, Griffiths EJ, Geddes JM, Hu G, Jung WH, Kretschmer M, Saikia S, Wang J. 2011. Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box. Nat Rev Microbiol 9:193–203. https://doi.org/10.1038/nrmicro2522.
6. Clatworthy AE, Pierson E, Hung DT. 2007. Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol 3:541–548. https://doi.org/10.1038/nchembio.2007.24.
7. May RC, Stone NR, Wiesner DL, Bicanic T, Nielsen K. 2016. Cryptococcus: from environmental saprophyte to global pathogen. Nat Rev Microbiol 14:106–117. https://doi.org/10.1038/nrmicro.2015.6.
8. Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Chiller TM, Denning DW, Loyse A, Boulware DR. 2017. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis 17:873–881. https://doi.org/10.1016/S1473-3099(17)30243-8.
9. Rosas AL, Nosanchuk JD, Feldmesser M, Cox GM, McDade HC, Casadevall A. 2000. Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents. Infect Immun 68:2845–2853. https://doi.org/10.1128/IAI.68.5.2845-2853.2000.
10. Wang Y, Casadevall A. 1994. Susceptibility of melanized and non-melanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants. Infect Immun 62:3004–3007.
11. Kwon-Chung KJ, Polacheck I, Popkin TJ. 1982. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacteriol 150:1414–1421.
12. Kwon-Chung KJ, Rhodes JC. 1986. Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect Immun 51:218–223.
13. Salas SD, Bennett JE, Kwon-Chung KJ, Perfect JR, Williamson PR. 1996. Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans. J Exp Med 184:377–386. https://doi.org/10.1084/jem.184.2.377.
14. Kim J, Sudbery P. 2011. Candida albicans, a major human fungal pathogen. J Microbiol 49:171–177. https://doi.org/10.1007/s12275-011-1064-7.
15. Kidd SE, Chow Y, Mak S, Bach PJ, Chen H, Hingston AO, Kronstad JW, Bartlett KH. 2007. Characterization of environmental sources of the human and animal pathogen Cryptococcus gattii in British Columbia, Canada, and the Pacific Northwest of the United States. Appl Environ Microbiol 73:1433–1443. https://doi.org/10.1128/AEM.01330-06.
16. Singh D, Sharma KK, Jacob S, Gakhar SK. 2014. Molecular docking of laccase protein from Bacillus safensis DSKK5 isolated from earthworm gut: a novel method to study dye decolorization potential. Water Air Soil Pollut 225:2175. https://doi.org/10.1007/s11270-014-2175-7.
17. Bérdy J. 1974. Recent developments of antibiotic research and classification of antibiotics according to chemical structure. Adv Appl Microbiol 18:309–406. https://doi.org/10.1016/S0065-2164(08)70573-2.
18. Jung KW, Yang DH, Maeng S, Lee KT, So YS, Hong J, Choi J, Byun HJ, Kim H, Bang S, Song MH, Lee JW, Kim MS, Kim SY, Ji JH, Park G, Kwon H, Cha S, Meyers GL, Wang LL, Jang J, Janbon G, Adedoyin G, Kim T, Averette AK, Heitman J, Cheong E, Lee YH, Lee YW, Bahn YS. 2015. Systematic functional profiling of transcription factor networks in Cryptococcus neoformans. Nat Commun 6:6757. https://doi.org/10.1038/ncomms7757.
19. Cramer KL, Gerrald QD, Nichols CB, Price MS, Alspaugh JA. 2006. Transcription factor Nrg1 mediates capsule formation, stress response, and pathogenesis in Cryptococcus neoformans. Eukaryot Cell 5:1147–1156. https://doi.org/10.1128/EC.00145-06.
20. Bahn YS, Kojima K, Cox GM, Heitman J. 2005. Specialization of the HOG pathway and its impact on differentiation and virulence of Cryptococcus neoformans. Mol Biol Cell 16:2285–2300. https://doi.org/10.1091/mbc.E04-11-0987.
21. Kraus PR, Fox DS, Cox GM, Heitman J. 2003. The Cryptococcus neoformans MAP kinase Mpk1 regulates cell integrity in response to antifungal drugs and loss of calcineurin function. Mol Microbiol 48:1377–1387. https://doi.org/10.1046/j.1365-2958.2003.03508.x.
22. Banks IR, Specht CA, Donlin MJ, Gerik KJ, Levitz SM, Lodge JK. 2005. A chitin synthase and its regulator protein are critical for chitosan production and growth of the fungal pathogen Cryptococcus neoformans. Eukaryot Cell 4:1902–1912. https://doi.org/10.1128/EC.4.11.1902-1912.2005.
23. Baker LG, Specht CA, Donlin MJ, Lodge JK. 2007. Chitosan, the deacety-lated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans. Eukaryot Cell 6:855–867. https://doi.org/10.1128/EC.00399-06.
24. Rodrigues ML, Alvarez M, Fonseca FL, Casadevall A. 2008. Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylo-mannan. Eukaryot Cell 7:602–609. https://doi.org/10.1128/EC.00307-07.
25. Martinez LR, Casadevall A. 2015. Biofilm formation by Cryptococcus neoformans. Microbiol Spectr 3. https://doi.org/10.1128/microbiolspec.MB-0006-2014.
26. Gow NA, van de Veerdonk FL, Brown AJ, Netea MG. 2011. Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol 10:112–122. https://doi.org/10.1038/nrmicro2711.
27. Kojic EM, Darouiche RO. 2004. Candida infections of medical devices. Clin Microbiol Rev 17:255–267. https://doi.org/10.1128/CMR.17.2.255 -267.2004.
28. Whitman WB, Coleman DC, Wiebe WJ. 1998. Prokaryotes: the unseen majority. Proc Natl Acad Sci U S A 95:6578–6583. https://doi.org/10.1073/pnas.95.12.6578.
29. Curtis TP, Sloan WT, Scannell JW. 2002. Estimating prokaryotic diversity and its limits. Proc Natl Acad Sci U S A 99:10494–10499. https://doi.org/10.1073/pnas.142680199.
30. Peleg AY, Hogan DA, Mylonakis E. 2010. Medically important bacterial-fungal interactions. Nat Rev Microbiol 8:340–349. https://doi.org/10.1038/nrmicro2313.
31. Arvanitis M, Mylonakis E. 2015. Fungal-bacterial interactions and their relevance in health. Cell Microbiol 17:1442–1446. https://doi.org/10.1111/cmi.12493.
32. Wargo MJ, Hogan DA. 2006. Fungal-bacterial interactions: a mixed bag of mingling microbes. Curr Opin Microbiol 9:359–364. https://doi.org/10.1016/j.mib.2006.06.001.
33. Latgé JP. 2007. The cell wall: a carbohydrate armour for the fungal cell. Mol Microbiol 66:279–290. https://doi.org/10.1111/j.1365-2958.2007.05872.x.
34. Reese AJ, Doering TL. 2003. Cell wall alpha-1,3-glucan is required to anchor the Cryptococcus neoformans capsule. Mol Microbiol 50: 1401–1409. https://doi.org/10.1046/j.1365-2958.2003.03780.x.
35. Chang YC, Kwon-Chung KJ. 1994. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol 14:4912–4919. https://doi.org/10.1128/MCB.14.7.4912.
36. Chang YC, Penoyer LA, Kwon-Chung KJ. 1996. The second capsule gene of Cryptococcus neoformans, CAP64, is essential for virulence. Infect Immun 64:1977–1983.
37. Ruiz A, Neilson JB, Bulmer GS. 1982. Control of Cryptococcus neoformans in nature by biotic factors. Sabouraudia 20:21–29. https://doi.org/10.1080/00362178285380051.
38. Steenbergen JN, Shuman HA, Casadevall A. 2001. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci U S A 98:15245–15250. https://doi.org/10.1073/pnas.261418798.
39. Abdulkareem AF, Lee HH, Ahmadi M, Martinez LR. 2015. Fungal serotype-specific differences in bacterial-yeast interactions. Virulence 6:652–657. https://doi.org/10.1080/21505594.2015.1066962.
40. Mora I, Cabrefiga J, Montesinos E. 2015. Cyclic lipopeptide biosynthetic genes and products, and inhibitory activity of plant-associated Bacillus against phytopathogenic bacteria. PLoS One 10:e0127738. https://doi.org/10.1371/journal.pone.0127738.
41. Shank EA, Klepac-Ceraj V, Collado-Torres L, Powers GE, Losick R, Kolter R. 2011. Interspecies interactions that result in Bacillus subtilis forming biofilms are mediated mainly by members of its own genus. Proc Natl Acad Sci U S A 108:E1236–E1243. https://doi.org/10.1073/pnas.1103630108.
42. Satomi M, La Duc MT, Venkateswaran K. 2006. Bacillus safensis sp. nov., isolated from spacecraft and assembly-facility surfaces. Int J Syst Evol Microbiol 56:1735–1740. https://doi.org/10.1099/ijs.0.64189-0.
43. Link L, Sawyer J, Venkateswaran K, Nicholson W. 2004. Extreme spore UV resistance of Bacillus pumilus isolates obtained from an ultraclean spacecraft assembly facility. Microb Ecol 47:159–163. https://doi.org/10.1007/s00248-003-1029-4.
44. Handtke S, Schroeter R, Jürgen B, Methling K, Schlüter R, Albrecht D, van Hijum SA, Bongaerts J, Maurer KH, Lalk M, Schweder T, Hecker M, Voigt B. 2014. Bacillus pumilus reveals a remarkably high resistance to hydrogen peroxide provoked oxidative stress. PLoS One 9:e85625. https://doi.org/10.1371/journal.pone.0085625.
45. Ghasemi S, Ahmadian G, Jelodar NB, Rahimian H, Ghandili S, Dehestani A, Shariati P. 2010. Antifungal chitinases from Bacillus pumilus SG2: preliminary report. World J Microbiol Biotechnol 26:1437–1443. https://doi.org/10.1007/s11274-010-0318-6.
46. Dehestani A, Kazemitabar K, Ahmadian G, Jelodar NB, Salmanian AH, Seyedi M, Rahimian H, Ghasemi S. 2010. Chitinolytic and antifungal activity of a Bacillus pumilus chitinase expressed in Arabidopsis. Biotechnol Lett 32:539–546. https://doi.org/10.1007/s10529-009-0192-1.
47. Hong HA, Duc le H, Cutting SM. 2005. The use of bacterial spore formers as probiotics. FEMS Microbiol Rev 29:813–835. https://doi.org/10.1016/j.femsre.2004.12.001.
48. Pandya U, Saraf M. 2015. Purification and characterization of antifungal chitinase from Bacillus safensis MBCU6 and its application for production of chito-oligosaccharides. Biologia 70:863–868. https://doi.org/10.1515/biolog-2015-0112.
49. Santhanam R, Luu VT, Weinhold A, Goldberg J, Oh Y, Baldwin IT. 2015. Native root-associated bacteria rescue a plant from a sudden-wilt dis- ease that emerged during continuous cropping. Proc Natl Acad Sci U S A 112:E5013–E5020. https://doi.org/10.1073/pnas.1505765112.
50. Bartlett KH, Cheng PY, Duncan C, Galanis E, Hoang L, Kidd S, Lee MK, Lester S, MacDougall L, Mak S, Morshed M, Taylor M, Kronstad J. 2012. A decade of experience: Cryptococcus gattii in British Columbia. Mycopathologia 173:311–319. https://doi.org/10.1007/s11046-011-9475-x.
51. Fraser JA, Giles SS, Wenink EC, Geunes-Boyer SG, Wright JR, Diezmann S, Allen A, Stajich JE, Dietrich FS, Perfect JR, Heitman J. 2005. Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature 437:1360–1364. https://doi.org/10.1038/nature04220.
52. Kaeberlein T, Lewis K, Epstein SS. 2002. Isolating “uncultivable” microorganisms in pure culture in a simulated natural environment. Science 296:1127–1129. https://doi.org/10.1126/science.1070633.
53. Kearns DB. 2010. A field guide to bacterial swarming motility. Nat Rev Microbiol 8:634–644. https://doi.org/10.1038/nrmicro2405.
54. Angelini TE, Roper M, Kolter R, Weitz DA, Brenner MP. 2009. Bacillus subtilis spreads by surfing on waves of surfactant. Proc Natl Acad Sci U S A 106:18109–18113. https://doi.org/10.1073/pnas.0905890106.
55. Saito F, Ikeda R. 2005. Killing of Cryptococcus neoformans by Staphylococcus aureus: the role of cryptococcal capsular polysaccharide in the fungal-bacteria interaction. Med Mycol 43:603–612. https://doi.org/10.1080/13693780500078417.
56. Rella A, Yang MW, Gruber J, Montagna MT, Luberto C, Zhang YM, Del Poeta M. 2012. Pseudomonas aeruginosa inhibits the growth of Cryptococcus species. Mycopathologia 173:451–461. https://doi.org/10.1007/s11046-011-9494-7.
57. Zakikhany K, Naglik JR, Schmidt-Westhausen A, Holland G, Schaller M, Hube B. 2007. In vivo transcript profiling of Candida albicans identifies a gene essential for interepithelial dissemination. Cell Microbiol 9:2938–2954. https://doi.org/10.1111/j.1462-5822.2007.01009.x.
58. Dalle F, Wächtler B, L’Ollivier C, Holland G, Bannert N, Wilson D, Labruère C, Bonnin A, Hube B. 2010. Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes. Cell Microbiol 12:248–271. https://doi.org/10.1111/j.1462-5822.2009.01394.x.
59. Wächtler B, Wilson D, Haedicke K, Dalle F, Hube B. 2011. From attachment to damage: defined genes of Candida albicans mediate adhesion, invasion and damage during interaction with oral epithelial cells. PLoS One 6:e17046. https://doi.org/10.1371/journal.pone.0017046.
60. Adams DJ. 2004. Fungal cell wall chitinases and glucanases. Microbiology 150:2029–2035. https://doi.org/10.1099/mic.0.26980-0.
61. Fox SJ, Shelton BT, Kruppa MD. 2013. Characterization of genetic determinants that modulate Candida albicans filamentation in the presence of bacteria. PLoS One 8:e71939. https://doi.org/10.1371/journal.pone.0071939.
62. Hogan DA, Kolter R. 2002. Pseudomonas-Candida interactions: an ecological role for virulence factors. Science 296:2229–2232. https://doi.org/10.1126/science.1070784.
63. Hogan DA, Vik A, Kolter R. 2004. A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol Microbiol 54:1212–1223. https://doi.org/10.1111/j.1365-2958.2004.04349.x.
64. Peleg AY, Tampakakis E, Fuchs BB, Eliopoulos GM, Moellering RC, Jr, Mylonakis E. 2008. Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans. Proc Natl Acad Sci U S A 105:14585–14590. https://doi.org/10.1073/pnas.0805048105.
65. Morales DK, Grahl N, Okegbe C, Dietrich LE, Jacobs NJ, Hogan DA. 2013. Control of Candida albicans metabolism and biofilm formation by Pseudomonas aeruginosa phenazines. mBio 4:e00526-12. https://doi.org/10.1128/mBio.00526-12.
66. Chen AI, Dolben EF, Okegbe C, Harty CE, Golub Y, Thao S, Ha DG, Willger SD, O’Toole GA, Harwood CS, Dietrich LE, Hogan DA. 2014. Candida albicans ethanol stimulates Pseudomonas aeruginosa WspR-controlled biofilm formation as part of a cyclic relationship involving phenazines. PLoS Pathog 10:e1004480. https://doi.org/10.1371/journal.ppat.1004480.
67. Lopez-Medina E, Fan D, Coughlin LA, Ho EX, Lamont IL, Reimmann C, Hooper LV, Koh AY. 2015. Candida albicans inhibits Pseudomonas aeruginosa virulence through suppression of pyochelin and pyoverdine biosynthesis. PLoS Pathog 11:e1005129. https://doi.org/10.1371/journal.ppat.1005129.
68. Graham CE, Cruz MR, Garsin DA, Lorenz MC. 2017. Enterococcus faecalis bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of Candida albicans. Proc Natl Acad Sci U S A 114:4507–4512. https://doi.org/10.1073/pnas.1620432114.
69. Chang YC, Bien CM, Lee H, Espenshade PJ, Kwon-Chung KJ. 2007. Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in Cryptococcus neoformans. Mol Microbiol 64:614–629. https://doi.org/10.1111/j.1365-2958.2007.05676.x.
70. Yoo Y, Choi HT. 2014. Antifungal chitinase against human pathogenic yeasts from Coprinellus congregatus. J Microbiol 52:441–443. https://doi.org/10.1007/s12275-014-3257-3.
71. Zaragoza O, García-Rodas R, Nosanchuk JD, Cuenca-Estrella M, Rodríguez-Tudela JL, Casadevall A. 2010. Fungal cell gigantism during mammalian infection. PLoS Pathog 6:e1000945. https://doi.org/10.1371/journal.ppat.1000945.
72. Okagaki LH, Strain AK, Nielsen JN, Charlier C, Baltes NJ, Chrétien F, Heitman J, Dromer F, Nielsen K. 2010. Cryptococcal cell morphology affects host cell interactions and pathogenicity. PLoS Pathog 6:e1000953. https://doi.org/10.1371/journal.ppat.1000953.
73. Denning DW, Bromley MJ. 2015. Infectious disease. How to bolster the antifungal pipeline. Science 347:1414–1416. https://doi.org/10.1126/science.aaa6097.
74. Pianalto KM, Alspaugh JA. 2016. New horizons in antifungal therapy. J Fungi 2:26. https://doi.org/10.3390/jof2040026.
75. Vega K, Kalkum M. 2012. Chitin, chitinase responses, and invasive fungal infections. Int J Microbiol 2012:920459. https://doi.org/10.1155/2012/920459.
76. Gordon-Thomson C, Kumari A, Tomkins L, Holford P, Djordjevic JT, Wright LC, Sorrell TC, Moore GP. 2009. Chitotriosidase and gene therapy for fungal infections. Cell Mol Life Sci 66:1116–1125. https://doi.org/10.1007/s00018-009-8765-7.
77. van Eijk M, van Roomen CP, Renkema GH, Bussink AP, Andrews L, Blommaart EF, Sugar A, Verhoeven AJ, Boot RG, Aerts JM. 2005. Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity. Int Immunol 17:1505–1512. https://doi.org/10.1093/intimm/dxh328.
78. Wiesner DL, Specht CA, Lee CK, Smith KD, Mukaremera L, Lee ST, Lee CG, Elias JA, Nielsen JN, Boulware DR, Bohjanen PR, Jenkins MK, Levitz SM, Nielsen K. 2015. Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. PLoS Pathog 11:e1004701. https://doi.org/10.1371/journal.ppat.1004701.
79. Wang X, Li GH, Zou CG, Ji XL, Liu T, Zhao PJ, Liang LM, Xu JP, An ZQ, Zheng X, Qin YK, Tian MQ, Xu YY, Ma YC, Yu ZF, Huang XW, Liu SQ, Niu XM, Yang JK, Huang Y, Zhang KQ. 2014. Bacteria can mobilize nematode-trapping fungi to kill nematodes. Nat Commun 5:5776. https://doi.org/10.1038/ncomms6776.
80. Albuquerque P, Nicola AM, Nieves E, Paes HC, Williamson PR, Silva-Pereira I, Casadevall A. 2013. Quorum sensing-mediated, cell density-dependent regulation of growth and virulence in Cryptococcus neoformans. mBio 5:e00986-13. https://doi.org/10.1128/mBio.00986-13.
81. Jung WH, Saikia S, Hu G, Wang J, Fung CK, D’Souza C, White R, Kronstad JW. 2010. HapX positively and negatively regulates the transcriptional response to iron deprivation in Cryptococcus neoformans. PLoS Pathog 6:e1001209. https://doi.org/10.1371/journal.ppat.1001209.
82. Santiago-Tirado FH, Peng T, Yang M, Hang HC, Doering TL. 2015. A single protein S-acyl transferase acts through diverse substrates to determine cryptococcal morphology, stress tolerance, and pathogenic outcome. PLoS Pathog 11:e1004908. https://doi.org/10.1371/journal.ppat.1004908.
83. Ravi S, Pierce C, Witt C, Wormley FL, Jr. 2009. Biofilm formation by Cryptococcus neoformans under distinct environmental conditions. Mycopathologia 167:307–314. https://doi.org/10.1007/s11046-008-9180-6.
84. Vida TA, Emr SD. 1995. A new vital stain for visualizing vacuolar membrane dynamics and endocytosis in yeast. J Cell Biol 128:779–792. https://doi.org/10.1083/jcb.128.5.779.
85. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. 2012. Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676–682. https://doi.org/10.1038/nmeth.2019.